At $31 a day, is Vertex’s new non-addictive painkiller worth the price?
Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...
Vertex Pharmaceuticals' non-opioid pain medication gets FDA approval
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...
Pharmaceutical Technology6mon
Vertex’s blockbuster-in-waiting painkiller suzetrigine set for FDA review next year
meaning the drug has an expedited review process. The agency previously granted a rolling NDA submission to Vertex in April this year. Suzetrigine is a voltage-gated sodium channel inhibitor, ...
pharmaphorum12mon
Vertex seeks swift review of new CF triple after ph3 readout
Vertex Pharma has said it will use a priority review voucher (PRV) to speed up the FDA review of its new once-daily triple therapy for cystic fibrosis, which has just hit all its objectives in a ...
Reuters3d
US FDA approves Vertex's non-opioid painkiller
The Institute for Clinical and Economic Review (ICER), which is the cost-effectiveness watchdog, said in its draft report that Vertex's painkiller is cost-effective only at a low price ...
Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.